Analytical Chemistry
& Trace Analysis

Providing a comprehensive range of Analytical Chemistry services for diverse pharmaceutical applications.

From analytical method development and validation to routine testing and trace impurity analysis, Resolian is your trusted partner for ensuring product safety and quality.

Resolian’s specialists have experience handling all types of formulations, including challenging matrices, such as tablets, capsules, creams and ointments, nasal sprays, oligonucleotides, peptides, and other consumer products.

Reach out to us directly to learn more about Resolian’s Analytical Chemistry & Trace Analysis services.

Services in Detail

GMP Method Development, Transfer, and Validation: Resolian’s specialist team designs and optimizes novel test methods, routinely utilizing the chromatography and detection options listed below: 

  • SFC, UPLC, GC and HPLC
  • MS, MS/MS, QDa, FLD, FID, ECD, VWD and DAD
Forced Degradation and Impurity Profiling: Resolian’s Analytical Chemistry team can help you establish the impurity profile of your compounds via forced degradation studies.
 
Trace Impurity Testing: Resolian offers expertise in detecting and quantifying trace-level impurities, including Nitrosamines and Genotoxic Impurities.
 
Batch Release and Stability Study Support: The comprehensive support offered includes protocol development, analysis, and reporting, ensuring product consistency and compliance.
 
Routine and Pharmacopoeia Testing: Experienced scientists support routine and Pharmacopoeia testing while providing technical support and guidance for analytical challenges.
 
Appearance and Odor Assessment: Resolian conducts assessments for visible and sub-visible particulates, color, clarity, and odor, allowing assessment of product aesthetics and integrity.
 
Physico-Chemical Analysis: Capabilities cover pH measurements, selective ion content (e.g., fluoride), pKa/Ka determination, partition coefficient, viscosity analysis, moisture content assessment, and solubility studies.

Our
Resources

Our Resources

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.